Cite Filings / XERS
Feed Companies Filings Check
Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
Filings Financials Insiders Search text
All 346 Financials 79 Shareholder Meetings 5 Executive Compensation 68 Insider Trading 178 Beneficial Ownership Interest 18 Business Combinations 62 Public Offerings 19 Mutual Funds and ETFs 5 Others 48
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEFA14A Proxy Proxy Materials 2022-05-02
  3. DEFA14A Proxy Proxy Materials 2022-04-28
  4. S-8 Other Securities Offered to Employees in Benefit Plans 2022-03-11
  5. EFFECT Other Notice of Effectiveness 2022-02-07
  6. EFFECT Other Notice of Effectiveness 2022-02-07
  7. S-8 Other Securities Offered to Employees in Benefit Plans 2021-10-05
  8. 8-K12B Other 8-K12B 2021-10-05
  9. EFFECT Other Notice of Effectiveness 2021-07-29

Page 3 of 3 · 48 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…